Literature DB >> 17142841

Issues in human embryonic stem cell biology.

K Turksen1, M Rao.   

Abstract

Human embryonic stem cells (hESCs) derived from frozen unused blastocytes from in vitro fertilization clinics exhibit unlimited proliferative capacity, and are pluripotent. The ability to maintain hESCs cultures in an undifferentiated state in vitro and differentiate them along a given lineage in a controlled manner make these cells potentially invaluable in regenerative medicine. Recent developments in the generation of patient-specific hESCs as well as animal product-free culture systems are some of the latest developments in the field; however great challenges lie ahead before the therapeutic application of hESCs becomes a reality. This article addresses some of the successes and roadblocks concerning the hESCs field; including various political, ethical and scientific obstacles.

Entities:  

Mesh:

Year:  2005        PMID: 17142841     DOI: 10.1385/SCR:1:2:079

Source DB:  PubMed          Journal:  Stem Cell Rev        ISSN: 1550-8943            Impact factor:   5.739


  10 in total

1.  Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture.

Authors:  M Amit; M K Carpenter; M S Inokuma; C P Chiu; C P Harris; M A Waknitz; J Itskovitz-Eldor; J A Thomson
Journal:  Dev Biol       Date:  2000-11-15       Impact factor: 3.582

Review 2.  Cellular lifespan and senescence signaling in embryonic stem cells.

Authors:  Takumi Miura; Mark P Mattson; Mahendra S Rao
Journal:  Aging Cell       Date:  2004-12       Impact factor: 9.304

3.  Karyotypic stability, genotyping, differentiation, feeder-free maintenance, and gene expression sampling in three human embryonic stem cell lines derived prior to August 9, 2001.

Authors:  Sandii N Brimble; Xianmin Zeng; Deborah A Weiler; Yongquan Luo; Ying Liu; Ian G Lyons; William J Freed; Allan J Robins; Mahendra S Rao; Thomas C Schulz
Journal:  Stem Cells Dev       Date:  2004-12       Impact factor: 3.272

Review 4.  Conserved and divergent paths that regulate self-renewal in mouse and human embryonic stem cells.

Authors:  Mahendra Rao
Journal:  Dev Biol       Date:  2004-11-15       Impact factor: 3.582

5.  Patient-specific embryonic stem cells derived from human SCNT blastocysts.

Authors:  Woo Suk Hwang; Sung Il Roh; Byeong Chun Lee; Sung Keun Kang; Dae Kee Kwon; Sue Kim; Sun Jong Kim; Sun Woo Park; Hee Sun Kwon; Chang Kyu Lee; Jung Bok Lee; Jin Mee Kim; Curie Ahn; Sun Ha Paek; Sang Sik Chang; Jung Jin Koo; Hyun Soo Yoon; Jung Hye Hwang; Youn Young Hwang; Ye Soo Park; Sun Kyung Oh; Hee Sun Kim; Jong Hyuk Park; Shin Yong Moon; Gerald Schatten
Journal:  Science       Date:  2005-05-19       Impact factor: 47.728

6.  Human embryonic stem cells express an immunogenic nonhuman sialic acid.

Authors:  Maria J Martin; Alysson Muotri; Fred Gage; Ajit Varki
Journal:  Nat Med       Date:  2005-01-30       Impact factor: 53.440

7.  Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells.

Authors:  Ren-He Xu; Ruthann M Peck; Dong S Li; Xuezhu Feng; Tenneille Ludwig; James A Thomson
Journal:  Nat Methods       Date:  2005-02-17       Impact factor: 28.547

8.  Transcriptome profiling of human and murine ESCs identifies divergent paths required to maintain the stem cell state.

Authors:  Chia Lin Wei; Takumi Miura; Paul Robson; Sai-Kiang Lim; Xiu-Qin Xu; Mathia Yu-Chuan Lee; Sanjay Gupta; Lawrence Stanton; Yongquan Luo; Jacqui Schmitt; Scott Thies; Wei Wang; Irina Khrebtukova; Daixing Zhou; Edison T Liu; Yi Jun Ruan; Mahendra Rao; Bing Lim
Journal:  Stem Cells       Date:  2005-02       Impact factor: 6.277

9.  Embryonic stem cell lines derived from human blastocysts.

Authors:  J A Thomson; J Itskovitz-Eldor; S S Shapiro; M A Waknitz; J J Swiergiel; V S Marshall; J M Jones
Journal:  Science       Date:  1998-11-06       Impact factor: 47.728

10.  MPSS profiling of human embryonic stem cells.

Authors:  Ralph Brandenberger; Irina Khrebtukova; R Scott Thies; Takumi Miura; Cai Jingli; Raj Puri; Tom Vasicek; Jane Lebkowski; Mahendra Rao
Journal:  BMC Dev Biol       Date:  2004-08-10       Impact factor: 1.978

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.